FDA Takes Steps to Boost Generic Competition, Limit Prices

FDA Takes Steps to Boost Generic Competition, Limit Prices
Tommy Farmer/Tennessee Bureau of Investigation via AP

The Food and Drug Administration said it's taking steps to boost the number of generic prescription drugs on the market in an effort to make medicines more affordable and to prevent price gouging.

 



Comment
Show comments Hide Comments


Related Articles